Lactiplantibacillus plantarum

Metabolism

Lactiplantibacillus plantarum are homofermentative, aerotolerant Gram-positive bacteria that grow at 15 °C, but not at 45 °C, and produce both enantiomers of lactic acid (D and L). Many lactobacilli including L. plantarum are unusual in that they can respire oxygen and express cytochromes if heme and menaquinone are present in the growth medium. In the absence of heme and menaquinone, oxygen is consumed by NADH-peroxidase with hydrogen peroxide as intermediate and water as end product. The peroxide, it is presumed, acts as a weapon to exclude competing bacteria from the food source. In place of the protective enzyme superoxide dismutase present in almost all other oxygen-tolerant cells, this organism accumulates millimolar quantities of manganese polyphosphate. Manganese is also used by L. plantarum in a pseudo-catalase to lower reactive oxygen levels. Because the chemistry by which manganese complexes protect the cells from oxygen damage is subverted by iron, these cells contain virtually no iron atoms; in contrast, a cell of Escherichia coli of comparable volume contains over one-million iron atoms. Because of this, L. plantarum cannot be used to create active enzymes that require a heme complex, such as true catalases.

L. plantarum can also reduce insoluble terminal electron acceptors, such as iron oxides or solid electrodes through extracellular electron transfer when riboflavin and quinone (such as 1 4-dihydroxy-2-naphthoic acid, DHNA) are present. L. plantarum uses extracellular electron transfer to increase the NAD+/NADH ratio, accelerate fermentation, generate more ATP through the substrate-level phosphorylation, and accumulate more biomass.

Lactiplantibacillus plantarum, like many lactobacilli, can be cultured using MRS media.

Genomes

The genome sequencing of the lactic acid bacterium L. plantarum WCFS1 shows more molecular details. The chromosome contains 3,308,274 base pairs (GenBank: AL935263.1). The GC content of L. plantarum is 44.45% with the average protein count 3063. According to the experiment from Wageningen Centre for Food Sciences, the rRNA number of L. plantarum WCFS1 is 15, and the number or tRNA is 70.

Products

Silage

Lactiplantibacillus plantarum is the most common bacterium used in silage inoculants. During the anaerobic conditions of ensilage, these organisms quickly dominate the microbial population, and, within 48 hours, they begin to produce lactic and acetic acids via the Embden-Meyerhof Pathway, further diminishing their competition. Under these conditions, L. plantarum strains producing high levels of heterologous proteins have been found to remain highly competitive. This quality could allow this species to be utilized as an effective biological pretreatment for lignocellulosic biomass.

Food products

Lactiplantibacillus plantarum is commonly found in milk products, meat and a lot of vegetable fermentations including sauerkraut, pickles, brined olives, kimchi, Ogi, sourdough, tempoyak, and other fermented plant material, and also some cheeses, fermented sausages, and stockfish. The high levels of this organism in food also makes it an ideal candidate for the development of probiotics. In a 2008 study by Juana Frias et al., L. plantarum was applied to reduce the allergenicity of soy flour. The result showed that, compared to other microbes, L. plantarum-fermented soy flour showed the highest reduction in IgE immunoreactivity (96–99%), depending upon the sensitivity of the plasma used. L. plantarum is also found in dadiah, a traditional fermented buffalo milk of the Minangkabau people, native to Sumatra.

Lactobacillus plantarum strain K21 is a gram-positive bacteria isolated from fermented vegetables. It has the ability to hydrolyze bile salt when it is provided as a supplement. In fat mice, K21 also reduces the levels of cholesterol and triglyceride, and inhibits the accumulation of lipid in 3T3-L1 preadipocytes. Furthermore, it reduces the level of plasma leptin, mitigates liver damage and alleviates glucose intolerance. Finally K21 inhibits body weight gain and fat mass accumulation.

Therapeutics

Because it is abundant, of human origin, and easy to grow, L. plantarum has been tested for health effects. It has been identified as a probiotic, which suggests its value for further research and application. L. plantarum has significant antioxidant activities and also helps to maintain intestinal permeability. It is able to suppress the growth of gas-producing bacteria in the intestines and may benefit some patients who suffer from IBS. It helps to create microbe balance and stabilize digestive enzyme patterns. Lactiplantibacillus plantarum has been found in experiments to increase hippocampal brain derived neurotrophic factor, which means L. plantarum may have a beneficial role in the treatment of depression. The ability of L. plantarum to survive in the human gastro-intestinal tract makes it a possible in vivo delivery vehicle for therapeutic compounds or proteins.

Lactiplantibacillus plantarum is a constituent in VSL#3. This proprietary, standardized formulation of live bacteria may be used in combination with conventional therapies to treat ulcerative colitis and requires a prescription.

Antimicrobial property

The ability of L. plantarum to produce antimicrobial substances helps them survive in the gastrointestinal tract of humans. The antimicrobial substances produced have shown significant effect on Gram-positive and Gram-negative bacteria.

Activity against AIDS-defining illnesses

As a result of initial HIV infection, the gut has been found to be a prime center of immune activity.

• The immune systems' Paneth cells of the gut attack HIV by producing interleukin 1 beta (IL-1β), which results in extensive collateral damage—sloughing of tight intestinal lining, witnessed as severe diarrhea. This destruction of the gut lining allows fungal pathogens to invade, e.g., Cryptococcus species, resulting in an AIDS-defining illness such as cryptococcosis, representing 60% to 70% of all AIDS-defining cases, but not necessarily only the gut. In rhesus macaques, L. plantarum is able to reduce (destroy) IL-1β, resolving inflammation, and accelerating gut repair within hours.

Biochemistry

The entire genome has recently been sequenced, and promoter libraries have been developed for both conditional and constitutive gene expression, adding to the utility of L. plantarum. It is also commonly employed as the indicative organism in niacin bioassay experiments, in particular, AOAC International Official Method 944.13, as it is a niacin auxotroph.

References

References

1. (2024). "''Lactiplantibacillus plantarum'' Lp 39 is a facultative anaerobe, Gram-positive, rod-shaped human pathogen that was isolated from pickled cabbage.".
2. (2022). "Bac''Dive'' in 2022: the knowledge base for standardized bacterial and archaeal data". Nucleic Acids Research.
3. (March 2010). "The extracellular biology of the lactobacilli". FEMS Microbiology Reviews.
4. (April 2020). "A taxonomic note on the genus ''Lactobacillus'': Description of 23 novel genera, emended description of the genus ''Lactobacillus'' Beijerinck 1901, and union of ''Lactobacillaceae'' and ''Leuconostocaceae''". International Journal of Systematic and Evolutionary Microbiology.
5. (August 2017). "Lifestyles in transition: evolution and natural history of the genus Lactobacillus". FEMS Microbiology Reviews.
6. (December 2016). "Nomadic lifestyle of Lactobacillus plantarum revealed by comparative genomics of 54 strains isolated from different habitats". Environmental Microbiology.
7. (2010). "Olives and Olive Oil in Health and Disease Prevention".
8. E Giraud, B Lelong and M Raimbault. 1991. Influence of pH and initial lactate concentration on the growth of ''Lactobacillus plantarum''. Applied Microbiology and Biotechnology. 36(1):96–99.
9. "Z Matejčeková ''et al.'' 2016. Characterization of the growth of ''Lactobacillus plantarum'' in milk in dependence on temperature. Acta Chimica Slovaca. 9(2)104—108.".
10. (January 2014). "Development of freeze dried synbiotic formulation using a probiotic strain of Lactobacillus plantarum". Journal of Food Science and Technology.
11. (2015). "Lactic metabolism revisited: metabolism of lactic acid bacteria in food fermentations and food spoilage". Current Opinion in Food Science.
12. (2012-04-10). "Aerobic respiration metabolism in lactic acid bacteria and uses in biotechnology". Annual Review of Food Science and Technology.
13. (August 1983). "Functional significance of manganese catalase in Lactobacillus plantarum". Journal of Bacteriology.
14. (February 2022). "Extracellular electron transfer increases fermentation in lactic acid bacteria via a hybrid metabolism". eLife.
15. (2022-12-19). "The Differing Roles of Flavins and Quinones in Extracellular Electron Transfer in Lactiplantibacillus plantarum". Applied and Environmental Microbiology.
16. (January 2010). "Development of a minimal growth medium for Lactobacillus plantarum". Letters in Applied Microbiology.
17. "''Lactobacillus plantarum'' - microbewiki".
18. (November 2010). "Simultaneous consumption of pentose and hexose sugars: an optimal microbial phenotype for efficient fermentation of lignocellulosic biomass". Applied Microbiology and Biotechnology.
19. (May 2008). "Effect of glucose in removal of microcystin-LR by viable commercial probiotic strains and strains isolated from dadih fermented milk". Journal of Agricultural and Food Chemistry.
20. (2015). "Effect of Lactobacillus plantarum Strain K21 on High-Fat Diet-Fed Obese Mice". Evidence-Based Complementary and Alternative Medicine.
21. "''Lactobacillus plantarum'' {{!}} Viticulture & Enology".
22. (March 2013). "Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual research". Gut Pathogens.
23. (August 2009). "Treatment of irritable bowel syndrome with probiotics. An etiopathogenic approach at last?". Revista Española de Enfermedades Digestivas.
24. (March 2013). "Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: part III - convergence toward clinical trials". Gut Pathogens.
25. (2014). "Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease". Clinical and Experimental Gastroenterology.
26. {{EMedicine. article. 1167389. CNS Cryptococcosis in HIV
27. (2011). "Biotin, niacin, and pantothenic acid assay using lyophilized lactobacillus plantarum ATCC 8014". Journal of Nutritional Science and Vitaminology.
28. (December 2011). "B-group vitamin production by lactic acid bacteria--current knowledge and potential applications". Journal of Applied Microbiology.